Skip to Content

M159 M159 (Didanosine Delayed Release 125 mg)

Pill with imprint M159 M159 is White, Capsule-shape and has been identified as Didanosine Delayed Release 125 mg. It is supplied by Mylan Pharmaceuticals Inc..

Didanosine is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Didanosine 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M159 M159

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.